LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
NXGL
NEXGEL, Inc.
There isn't enough reported data to score NXGL yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
NXGL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
NXGL's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
NXGL PE Valuation
NXGL has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
NXGL Forward outlook
There aren't enough analyst estimates for NXGL to show an outlook.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over NXGL on earnings quality, reporting a profit while its opponent remains loss making.
NXGL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$14.20 | -$6.20 |
| Q1 2026 | -$8.00 | +$1.00 |
| Q4 2025 | -$7.60 | +$2.40 |
| Q3 2025 | -$7.40 | +$4.20 |
| Q2 2025 | -$8.00 | +$3.40 |
| Q1 2025 | -$9.00 | +$2.00 |
| Q4 2024 | -$10.00 | +$1.20 |
| Q3 2024 | -$11.60 | -$2.00 |
NXGL is still losing money, but far less than before: $14.20 per share over the past year, against $43.20 at its worst in late 2022.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over NXGL on profitability, with a higher operating margin.
NXGL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.7M | +28% |
| Q1 2026 | $2.7M | -5.6% |
| Q4 2025 | $2.8M | -8.1% |
| Q3 2025 | $2.9M | -0.2% |
| Q2 2025 | $2.9M | +100% |
| Q1 2025 | $2.8M | +122% |
| Q4 2024 | $3M | +181% |
| Q3 2024 | $2.9M | +141% |
NXGL's revenue has held roughly level: $4M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -68% | -46 points |
| Q1 2026 | -36% | -8.5 points |
| Q4 2025 | -43% | -16 points |
| Q3 2025 | -25% | +2.1 points |
| Q2 2025 | -22% | +51 points |
| Q1 2025 | -28% | +41 points |
| Q4 2024 | -28% | +85 points |
| Q3 2024 | -27% | +23 points |
NXGL's operating margin was −68% last quarter, down 46 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with NXGL at up 0.1%.
NXGL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $241K | +$1.2M |
| Q3 2025 | -$793K | +$436K |
| Q4 2024 | -$928K | -$256K |
| Q3 2024 | -$1.2M | -$148K |
| Q2 2024 | -$909K | +$473K |
| Q1 2024 | -$1.2M | -$447K |
| Q4 2023 | -$672K | -$15K |
| Q3 2023 | -$1.1M | -$176K |
NXGL has burned cash in almost every quarter: −$3M over the past year, against −$4M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over NXGL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
NXGL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.9% | +40.5K shares |
| 1 year | +18% | +67.9K shares |
| 3 years | +62% | +172K shares |
NXGL has 450,663 diluted shares, up 18% from a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
NXGL Net Leverage
NXGL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
NXGL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.8 | Neutral |
| Stochastic | 7.2 | Oversold |
NXGL's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
NXGL PE vs Healthcare Sector
NXGL has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over NXGL on trend strength, trading above more of its moving averages.
NXGL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.06 | 6.7% below |
| 20 week MA | $6.53 | 42% below |
| 50 week MA | $14.7 | 74% below |
| 100 week MA | $34.7 | 89% below |
| 200 week MA | $39.9 | 90% below |
NXGL is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over NXGL on returns for 2026, with the stronger performance.
NXGL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $62.4 | $62.4 | 0% |
| 2022 | $62.4 | $27.2 | -56% |
| 2023 | $27.2 | $42.6 | +57% |
| 2024 | $42.6 | $94.0 | +121% |
| 2025 | $94.0 | $30.6 | -67% |
| 2026 YTD | $30.6 | $3.79 | -88% |
NXGL's yearly returns have swung widely, from +121% in 2024 to −67% in 2025. It's down 88% so far in 2026.